Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 Study.
Valle, Juan W Palmer, D Jackson, R Cox, T Neoptolemos, J Ghaneh, P Rawcliffe, C Bassi, C Stocken, D Cunningham, D
Valle, Juan W
Palmer, D
Jackson, R
Cox, T
Neoptolemos, J
Ghaneh, P
Rawcliffe, C
Bassi, C
Stocken, D
Cunningham, D
Citations
Altmetric:
Abstract
Adjuvant chemotherapy improves patient survival rates after resection for pancreatic adenocarcinoma, but the optimal duration and time to initiate chemotherapy is unknown.
Authors
Valle, Juan W
Palmer, D
Jackson, R
Cox, T
Neoptolemos, J
Ghaneh, P
Rawcliffe, C
Bassi, C
Stocken, D
Cunningham, D
O'Reilly, Derek
Goldstein, D
Robinson, B
Karapetis, C
Scarfe, A
Lacaine, F
Sand, J
Izbicki, J
Mayerle, J
Dervenis, C
Oláh, A
Butturini, G
Lind, P
Middleton, M
Anthoney, A
Sumpter, K
Carter, R
Büchler, M
Palmer, D
Jackson, R
Cox, T
Neoptolemos, J
Ghaneh, P
Rawcliffe, C
Bassi, C
Stocken, D
Cunningham, D
O'Reilly, Derek
Goldstein, D
Robinson, B
Karapetis, C
Scarfe, A
Lacaine, F
Sand, J
Izbicki, J
Mayerle, J
Dervenis, C
Oláh, A
Butturini, G
Lind, P
Middleton, M
Anthoney, A
Sumpter, K
Carter, R
Büchler, M
Affiliation
Description
Date
2014-01-13
Publisher
Collections
Keywords
Type
Article
Citation
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 Study. 2014: J Clin Oncol